BioRestorative Therapies, Inc. ("BRT" or the "Company")
(OTCBB:BRTX), a life sciences company focused on adult stem
cell-based cellular therapies for various personal medical applications,
today announced the appointment of The Honorable Paul Jude Tonna to its
Board of Directors. Mr. Tonna will serve on the Audit, Compensation and
Nominating committees of the Board.
Mr. Tonna is a highly regarded community leader and an accomplished
businessman with an extensive history of public service. From 1994 to
2005 he served as a Suffolk County Legislator, and from 2000 through
2002 was its Presiding Officer. He currently serves as Executive
Director and a member of the Board of Advisors for The Energeia
Partnership at Molloy College, a leadership academy based in Rockville
Centre, New York, dedicated to identifying and addressing the serious,
complex and multi-dimensional issues challenging the Long Island region.
Mr. Tonna is a former Adjunct Professor in Theology & Religious Studies
at St. John’s University. He served as Chairman of the Suffolk County
Industrial Development Agency and currently serves as Public Trustee of
the Stationary Engineer’s Industry Stabilization Fund. Mr. Tonna is a
board member of The Advanced Energy Research & Technology Center at
Stony Brook University, The Long Island Index Advisory Board and Erase
Racism’s College of Advisors. He also serves as the Executive Director
of the Suffolk County Village Officials Association and the United
States Green Building Council-Long Island Chapter. Mr. Tonna is a
founding director of Empire National Bank and Chairman and Commissioner
of the South Huntington Water District.
“We are delighted to welcome Paul to the Board of Directors of
BioRestorative Therapies,” said Mark Weinreb, the Company’s Chief
Executive Officer. “He is a tireless advocate for so many social causes,
including the environment, affordable housing, poverty and immigrant
rights, and is the recipient of a host of awards and honors from a
multitude of diverse groups. He is a remarkable man and we are excited
to be able to draw from his wisdom as BioRestorative Therapies evolves.”
Mr. Tonna holds an undergraduate degree in philosophy from New York
University and a master’s degree in theology from Immaculate Conception
Seminary, and he conducted doctoral studies in systemic theology at
Fordham University.
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (www.biorestorative.com)
develops products and medical procedures using cell and tissue
protocols, primarily involving adult stem cells, including:
-
brtxDISC™ (Disc Implanted Stem Cells)
is an investigational non-surgical treatment for bulging and herniated
lumbar discs that is intended for patients who have failed
non-invasive procedures and face the prospect of surgery. The
treatment involves culturing a patient’s own stem cells and then
delivering them via a proprietary medical device to the damaged region
of the disc in an outpatient procedure.
-
ThermoStem® is a treatment using brown fat stem cells that is
under development for metabolic disorders including diabetes and
obesity. Initial preclinical research indicates that increased amounts
of brown fat in the body may be responsible for additional caloric
burning as well as reduced glucose and lipid levels.
-
brtx-C Cosmetic is based on the development of a human cellular
extract that has been demonstrated in in vitro skin studies to
increase the production of collagen and fibronectin, which are
proteins that are essential to combating the aging of skin. Potential
cosmetic uses are being explored with third parties.
The Company also offers plant stem cell-based facial creams and beauty
products under the Stem Pearls® brand at www.stempearls.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. You
are cautioned that such statements are subject to a multitude of risks
and uncertainties that could cause future circumstances, events or
results to differ materially from those projected in the forward-looking
statements as a result of various factors and other risks, including
those set forth in the Company's Form 10-K filed with the Securities and
Exchange Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance
on such statements. The forward-looking statements in this release are
made as of the date hereof and the Company undertakes no obligation to
update such statements.
Copyright Business Wire 2014